Cargando…
New Potential Immune Biomarkers in the Era of Precision Medicine: Lights and Shadows in Colorectal Cancer
Genetic alterations in CRC have shown a negative predictive and prognostic role in specific target therapies. The onset of immunotherapy has also undergone remarkable therapeutic innovation, although limited to a small subgroup of patients, the MSI-H/dMMR, which represents only 5% of CRC. Research i...
Autores principales: | Damato, Angela, Rotolo, Martina, Caputo, Francesco, Borghi, Eleonora, Iachetta, Francesco, Pinto, Carmine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410155/ https://www.ncbi.nlm.nih.gov/pubmed/36013315 http://dx.doi.org/10.3390/life12081137 |
Ejemplares similares
-
FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial
por: Damato, Angela, et al.
Publicado: (2021) -
Pharmacologicaltreatment of COVID-19: lights and shadows
por: Menzella, Francesco, et al.
Publicado: (2020) -
Precision Medicine and Precision Nursing: The Era of Biomarkers and Precision Health
por: Ielapi, Nicola, et al.
Publicado: (2020) -
The slow-paced digital evolution of pathology: lights and shadows from a multifaceted board
por: Caputo, Alessandro, et al.
Publicado: (2023) -
The Light and Shadow of Senescence and Inflammation in Cardiovascular Pathology and Regenerative Medicine
por: Iop, Laura, et al.
Publicado: (2017)